Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Receivables (2018 - 2025)

AdaptHealth has reported Receivables over the past 8 years, most recently at $415.6 million for Q4 2025.

  • Quarterly results put Receivables at $415.6 million for Q4 2025, down 7.57% from a year ago — trailing twelve months through Dec 2025 was $415.6 million (down 7.57% YoY), and the annual figure for FY2025 was $415.6 million, down 7.57%.
  • Receivables for Q4 2025 was $415.6 million at AdaptHealth, up from $412.5 million in the prior quarter.
  • Over the last five years, Receivables for AHCO hit a ceiling of $477.3 million in Q2 2024 and a floor of $274.6 million in Q1 2021.
  • Median Receivables over the past 5 years was $407.8 million (2023), compared with a mean of $404.1 million.
  • Biggest five-year swings in Receivables: soared 135.53% in 2021 and later fell 10.58% in 2025.
  • AdaptHealth's Receivables stood at $383.7 million in 2021, then rose by 3.66% to $397.7 million in 2022, then increased by 14.98% to $457.3 million in 2023, then dropped by 1.68% to $449.6 million in 2024, then fell by 7.57% to $415.6 million in 2025.
  • The last three reported values for Receivables were $415.6 million (Q4 2025), $412.5 million (Q3 2025), and $426.8 million (Q2 2025) per Business Quant data.